Tower Research Capital (TRC)’s BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant BOAS.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-606
Closed -$6K 6891
2022
Q3
$6K Hold
606
﹤0.01% 5111
2022
Q2
$6K Hold
606
﹤0.01% 5016
2022
Q1
$6K Hold
606
﹤0.01% 4996
2021
Q4
$6K Sell
606
-100
-14% -$994 ﹤0.01% 5109
2021
Q3
$7K Buy
+706
New +$7K ﹤0.01% 4715

Tower Research Capital (TRC)'s BOAS.U Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant (BOAS.U) in Q4 2022, closing a stake of 606 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in BOAS.U in Q3 2021 and held it in 5 quarters. The position peaked at $7K in Q3 2021. 0 funds tracked by Wall St. Rank hold BOAS.U as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 606 BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant shares in Q4 2022, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant in Q3 2021 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant position peaked at $7K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.